Eastover Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-73,415
Closed -$4.26M 45
2023
Q3
$4.26M Buy
73,415
+2,363
+3% +$145K 2.56% 23
2023
Q2
$4.54M Buy
71,052
+311
+0.4% +$20.9K 2.42% 26
2023
Q1
$4.9M Buy
70,741
+1,355
+2% +$95.6K 2.74% 23
2022
Q4
$4.99M Buy
69,386
+770
+1% +$58.1K 2.86% 23
2022
Q3
$4.78M Buy
68,616
+1,058
+2% +$76.7K 2.98% 20
2022
Q2
$5.2M Sell
67,558
-5,610
-8% -$427K 3.17% 18
2022
Q1
$5.34M Buy
73,168
+8,414
+13% +$565K 2.82% 19
2021
Q4
$4.04M Buy
64,754
+1,975
+3% +$116K 2.33% 24
2021
Q3
$3.71M Buy
62,779
+241
+0.4% +$15.9K 2.42% 25
2021
Q2
$4.18M Buy
62,538
+3,619
+6% +$236K 2.71% 20
2021
Q1
$3.72M Sell
58,919
-1,984
-3% -$123K 2.63% 22
2020
Q4
$3.78M Buy
60,903
+73
+0.1% +$4.49K 2.62% 21
2020
Q3
$3.67M Buy
60,830
+1,321
+2% +$79.5K 2.79% 22
2020
Q2
$3.5M Buy
59,509
+1,990
+3% +$119K 2.89% 19
2020
Q1
$3.21M Buy
+57,519
New +$3.52M 3.11% 13

Other funds holding BMY

Eastover Investment Advisors's BMY Position: Q4 2023 in Review

Eastover Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 73,415 shares — an estimated $4.26M sold.

Eastover Investment Advisors first reported a position in BMY in Q1 2020 and held it in 15 quarters. The position peaked at $5.34M in Q1 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Eastover Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Eastover Investment Advisors sold 73,415 Bristol-Myers Squibb shares in Q4 2023, an estimated $4.26M.
  • Eastover Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 15 quarters.
  • Eastover Investment Advisors's Bristol-Myers Squibb position peaked at $5.34M in Q1 2022.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Eastover Investment Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.